Literature DB >> 11206961

Indications for red cell transfusion in sickle cell disease.

K Ohene-Frempong1.   

Abstract

Transfusion of red blood cells is an important therapeutic method employed in the care of people with sickle cell disease (SCD). There are several clinical situations in which patients with SCD clearly need red cell transfusion (RCT). In other situations, the indication for RCT is doubtful, controversial, or III-advised. RCT is used on either an episodic or chronic basis in the management of SCD. Episodic transfusions are usually applied in a patient who has already developed a serious complication of SCD or are used to reduce the chances for the development of a complication. Chronic transfusion therapy is often used to prevent the recurrence of a major complication such as a stroke. Recently, chronic transfusion has been applied to patients with evidence of cerebrovascular disease to prevent the first occurrence of stroke.

Entities:  

Mesh:

Year:  2001        PMID: 11206961     DOI: 10.1053/shem.2001.20139

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  14 in total

1.  Recommendations for the transfusion of red blood cells.

Authors:  Giancarlo Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2009-01       Impact factor: 3.443

2.  Exhaled carbon monoxide levels in children with sickle cell disease.

Authors:  Karl P Sylvester; Richard A Patey; Gerrard F Rafferty; David Rees; Swee Lay Thein; Anne Greenough
Journal:  Eur J Pediatr       Date:  2004-12-15       Impact factor: 3.183

Review 3.  Transfusion in Haemoglobinopathies: Review and recommendations for local blood banks and transfusion services in Oman.

Authors:  Arwa Z Al-Riyami; Shahina Daar
Journal:  Sultan Qaboos Univ Med J       Date:  2018-04-04

Review 4.  Improving outcomes in children with sickle cell disease: treatment considerations and strategies.

Authors:  Ali Amid; Isaac Odame
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

5.  Delayed hemolytic transfusion reaction in children with sickle cell disease.

Authors:  Mariane de Montalembert; Marie-Dominique Dumont; Claire Heilbronner; Valentine Brousse; Oussama Charrara; Béatrice Pellegrino; Christophe Piguet; Valérie Soussan; France Noizat-Pirenne
Journal:  Haematologica       Date:  2011-02-17       Impact factor: 9.941

6.  Trends in blood transfusion among hospitalized children with sickle cell disease.

Authors:  Jean L Raphael; Suzette O Oyeku; Marc A Kowalkowski; Brigitta U Mueller; Angela M Ellison
Journal:  Pediatr Blood Cancer       Date:  2013-06-18       Impact factor: 3.167

Review 7.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

8.  Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.

Authors:  Ellen B Fung; Paul R Harmatz; Meredith Milet; Vinod Balasa; Samir K Ballas; James F Casella; Lee Hilliard; Abdullah Kutlar; Kenneth L McClain; Nancy F Olivieri; John B Porter; Elliott P Vichinsky
Journal:  Transfusion       Date:  2008-05-29       Impact factor: 3.157

9.  Blood component therapy.

Authors:  Anupam Verma
Journal:  Indian J Pediatr       Date:  2008-08-21       Impact factor: 1.967

Review 10.  Cardiac pathophysiology in sickle cell disease.

Authors:  Oluwabukola Temitope Gbotosho; Michael Taylor; Punam Malik
Journal:  J Thromb Thrombolysis       Date:  2021-03-07       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.